Table 1 Baseline characteristics

Age (years)

59.34 ± 11.71

61.61 ± 12.85

64.29 ± 10.84 ^#

Male (%)

149 (85.6%)

52 (81.3%)

80 (71.4%)^#

Prior CHD (%)

30 (17.2%)

15 (23.4%)

30 (26.8%)

Hypertension (%)

80 (46%)

43 (67.2%)^#

66 (58.9%)^#

Prior Stroke (%)

16 (9.2%)

9 (14.1%)

13 (11.6%)

Prior PCI (%)

12 (6.9%)

8 (12.5%)

15 (13.3%)

Multivessel disease

90 (51.8%)

42 (65.6%)

88 (78.6%)^#

Killip class 3–4 (%)

8 (4.6%)

3 (4.6%)

12 (10.7%) ^#

 Glucose (mmol/L)

5.69

(5.05–6.60)

6.65 ^#

(6.15–7.97)

11.11 ^{# *}

(7.85–13.76)

 HbA1c (%)

5.60

(5.30–5.90)

6.60 ^#

(6.10–6.90)

7.80 ^{# *}

(7.30–9.58)

 Hemoglobin(g/L)

148.63 ± 15.05

144.94 ± 16.58

143.36 ± 17.26^#

 TG (mmol/L)

1.46

(1.07–2.04)

1.51

(1.04–2.10)

1.70 ^{# *}

(1.22–2.30)

 HDL-C (mmol/L)

1.24

(0.99–1.47)

1.23

(0.99–1.46)

1.20

(0.99–1.43)

 LDL-C (mmol/L)

2.72

(2.20–3.33)

2.73

(2.22–3.35)

2.77

(2.26–3.35)

 Apo AI (g/L)

1.14

(0.96–1.33)

1.17

(0.99–1.35)

1.17

(1.01–1.24)

 Apo B (g/L)

0.84

(0.68–0.97)

0.85

(0.69–0.97)

0.88 ^{# *}

(0.79–1.02)

 Creatinine(umol/L)

68.00

(61.00–78.25)

68.50

(61.00–80.75)

67.50

(57.00–79.75)

 Aspirin

21 (12.5%)

17 (27.4%)^#

20 (17.9%)

 Clopidogrel

12 (7.1%)

7(11.3%)

11 (9.8%)

 Statin

11 (6.5%)

9 (14.5%)

16 (14.2%)

 Beta-blocker

16 (9.5%)

12 (19.4%)^#

21 (18.8%)^#

 ACEI

11 (6.5%)

5 (8.1%)

17 (15.1%) ^#

 Insulin

19(10.9%)

10(15.6%)

63(56.3%) ^{# *}

 Beta-blocker

155(89.1%)

58(90.6%)

101(90.2%)

 ACEI

155(89.1%)

62(96.9%)

106(94.6%)